Morpholino

MO4-cyp19a1b

ID
ZDB-MRPHLNO-180918-2
Name
MO4-cyp19a1b
Previous Names
None
Target
Sequence
5' - ATCCTTTACCACATGCTCCATCATC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO4-cyp19a1b
No data available
Phenotype
Phenotype resulting from MO4-cyp19a1b
Phenotype of all Fish created by or utilizing MO4-cyp19a1b
Phenotype Fish Conditions Figures
visual behavior process characteristic, abnormal AB + MO4-cyp19a1b standard conditions Fig. 4 from Ulhaq et al., 2025
retinal pigmented epithelium apoptotic process increased occurrence, abnormal AB + MO4-cyp19a1b standard conditions Fig. 3 from Ulhaq et al., 2025
eye 17beta-estradiol decreased amount, abnormal AB + MO4-cyp19a1b standard conditions Fig. 1 from Ulhaq et al., 2025
optomotor response decreased process quality, abnormal AB + MO4-cyp19a1b standard conditions Fig. 4 from Ulhaq et al., 2025
retinal photoreceptor layer decreased thickness, abnormal AB + MO4-cyp19a1b standard conditions Fig. 3 from Ulhaq et al., 2025
retinal inner nuclear layer cyp19a1b expression decreased amount, abnormal AB + MO4-cyp19a1b standard conditions Fig. 1 from Ulhaq et al., 2025
eye apoptotic process increased occurrence, abnormal AB + MO4-cyp19a1b standard conditions Fig. 3 from Ulhaq et al., 2025
retinal pigmented epithelium decreased thickness, abnormal AB + MO4-cyp19a1b standard conditions Fig. 3 from Ulhaq et al., 2025
retinal outer nuclear layer decreased thickness, abnormal AB + MO4-cyp19a1b standard conditions Fig. 3 from Ulhaq et al., 2025
cranial nerve II decreased diameter, abnormal AB + MO4-cyp19a1b standard conditions Fig. 2 from Ulhaq et al., 2025
retinal ganglion cell layer cyp19a1b expression decreased amount, abnormal AB + MO4-cyp19a1b standard conditions Fig. 1 from Ulhaq et al., 2025
eye decreased size, abnormal AB + MO4-cyp19a1b standard conditions Fig. 2 from Ulhaq et al., 2025
heart blood volume, ameliorated WT + MO4-cyp19a1b chemical treatment by environment: 17beta-estradiol Figure 2. with image from Ulhaq, 2019
cardiac ventricle length, ameliorated WT + MO4-cyp19a1b chemical treatment by environment: 17beta-estradiol Figure 2. with image from Ulhaq, 2019
cardiac ventricle decreased length, abnormal WT + MO4-cyp19a1b standard conditions Figure 1. with image from Ulhaq, 2019
heart blood decreased volume, abnormal WT + MO4-cyp19a1b standard conditions Figure 1. with image from Ulhaq, 2019
Citations